| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $371.64M | $121.19M | $126.04M | $93.42M | $69.02M |
| R&D | $321.53M | $93.31M | $94.31M | $64.55M | $47.53M |
| SG&A | $50.11M | $27.88M | $31.72M | $28.87M | $21.49M |
| Operating Income | -$371.64M | -$121.19M | -$126.04M | -$93.42M | -$69.02M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$695.98M | -$116.91M | -$117.86M | -$92.09M | -$68.90M |
| EPS (basic) | -70.5000 | -1.7000 | -1.7500 | -2.3300 | -2.1000 |
| EPS (diluted) | -70.5000 | -1.7000 | -1.7500 | -2.3300 | -2.1000 |
| Shares (diluted) | $9.87M | $68.71M | $67.19M | $39.55M | $33.43M |